Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Better MedSpa vs Meto

Better MedSpa
Graded #402

Lower grade

vs+4.799999999999997
Meto
Graded #278

Higher grade

The verdict

Meto takes it — 62/100 to 57.2/100.

Meto grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Meto is an insurance-accepting metabolic telehealth platform offering compounded semaglutide and compounded tirzepatide, prescribed after clinician-ordered lab work.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationBetter MedSpa +16
56
40
Clinical oversightMeto +11
77
88
Labs & monitoringMeto +33
52
85
FulfillmentMeto +7
60
67
Contract termsEven
55
55
Better MedSpa · left barMeto · right bar

The numbers

MetricBetter MedSpaMeto
WeighScore57.2/10062/100
GradeCC
Scorecard rank#402#278
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
Coverage1 stateCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Better MedSpa

Graded #402 · C

Strengths

  • Broad menu: semaglutide, tirzepatide, and liraglutide
  • Both oral and injectable formulations offered
  • Physician-led; medical director Dr. Brett Brechner, DO
  • Both in-person Chicago visits and statewide telehealth
  • Doorstep delivery throughout Illinois

Where it loses points

  • Telehealth limited to Illinois only
  • No pricing published online
  • Compounded vs brand formulation not specified
  • Med-spa positioning blends weight loss with aesthetics
Meto

Graded #278 · C

Strengths

  • Accepts major insurance (Blue Cross, Anthem, United, Aetna) — most patients pay $0–50 per visit
  • Requires lab work before prescribing GLP-1s; addresses root-cause metabolic drivers
  • Matches patients with endocrinologists and obesity medicine specialists within minutes
  • Offers compounded semaglutide and tirzepatide with board-certified physician oversight
  • Handles all prior-auth paperwork; provider location pages exist for all 50 US states

Where it loses points

  • Medication pricing fully gated behind quiz — no public cash price for sema or tirz
  • Lab panels are a separate out-of-pocket cost ($199–$399) unless covered by insurance
  • No LegitScript certification or named compounding pharmacy found on any public page
  • Company leadership and clinical team not disclosed publicly
  • Self-pay cash pricing exists per site copy but is not published anywhere

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard